Skip to content

PHARMACIE E. DOZOT

Active
Private limited companyfounded 1991active for 35 yearsRue de Liège 3, 5300 Andenne, BelgiumKBO/BCE: BE 0444.430.838

From the official registers: KBO 34 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

The computed 12-month bankruptcy probability of PHARMACIE E. DOZOT is 1.5% (moderate). The 2025 annual accounts show negative equity (-€147,015) and a net result of €38,700. Equity has been shrinking by about 12% per year since 2018. Its solvency ranks better than 8% of 12,757 sector peers (NACE 47, financial year 2025). The company has been active since 1991 and the Belgian Official Gazette contains no insolvency or warning signals.

Overview

Official details

KBO
Status
Active since 21-06-1991 Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730
Establishment unit
2.053.391.416 5300 Andenne, since 09-07-1991
Financial year end
31 December
Peppol
Reachable since 03-09-2025

Board and ownership

Board

Financial position

54 Fair Checked score 2025
Bankruptcy probabilitywithin 12 months
1.5%
Annual accounts 2025
Gross margin
€293,770
▲ 17.7%
Turnover
≈ €1.1m
estimated
Profit
€38,700
▲ 200%
Equity
-€147,015
▲ 20.8%
Total assets
€491,246
▲ 7.7%
Staff
3.6 FTE
▲ 5.9%
Filed on 18-08-2026, 18 days after the deadlineat the National Bank
Score breakdownraises riskCapped at 59: negative equityNegative equity -€147,015Sector: Retail trade (NACE 47)Last filed accounts filed 18 days late; 2 of the last 3 accounts latelowers riskFounded in 1991Show the evidence

Checked score

Score 2025
54 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially stronger than 35% of micro companies in retail trade (NACE 47)
Negative equity caps the score at 59. Every signal that counts is listed under Signals.
Financial strength · tick: 2024
Weak
Solvency 0=
equity -29.9% of total assets
Liquidity 16-4
short-term debt 115.0% · cash 12.6%
Profitability 63+17
return on assets 7.9%
Bankruptcy probability within 12 months
1.5% Moderate
0%0.5%1.5%4%10%≥ 25%

About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,270 companies, NACE 47, micro)
Last 24 months 11-2024: 3.0% 12-2024: 3.0%● unchanged vs 11-2024 01-2025: 3.0%● unchanged vs 12-2024 02-2025: 3.0%● unchanged vs 01-2025 03-2025: 2.9%▼ -0.1 percentage points vs 02-2025 04-2025: 2.9%● unchanged vs 03-2025 05-2025: 2.9%● unchanged vs 04-2025 06-2025: 2.8%▼ -0.1 percentage points vs 05-2025 07-2025: 3.0%▲ +0.2 percentage points vs 06-2025 08-2025: 3.4%▲ +0.4 percentage points vs 07-2025highest value 09-2025: 1.6%▼ -1.8 percentage points vs 08-2025 10-2025: 1.6%● unchanged vs 09-2025 11-2025: 1.6%● unchanged vs 10-2025 12-2025: 1.6%● unchanged vs 11-2025 01-2026: 1.6%● unchanged vs 12-2025 02-2026: 1.6%● unchanged vs 01-2026 03-2026: 1.6%● unchanged vs 02-2026 04-2026: 1.6%● unchanged vs 03-2026 05-2026: 1.6%● unchanged vs 04-2026 06-2026: 1.5%▼ -0.1 percentage points vs 05-2026lowest value 07-2026: 1.6%▲ +0.1 percentage points vs 06-2026 08-2026: 1.9%▲ +0.3 percentage points vs 07-2026 09-2026: 1.5%▼ -0.4 percentage points vs 08-2026 10-2026: 1.5%● unchanged vs 09-2026
No credit on open account
Liquidity is insufficient, with a current ratio of 0.71 (0.66 in 2024), below 1. Short-term debt is 115% and cash 12.6% of total assets. Equity is negative.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 6% of them on solvency, 15% on liquidity, 44% on profitability and 73% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises risk
raises risk · Negative equity -€147,015
NBB · annual accounts
lowers risk · Founded in 1991
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
raises risk · Sector: Retail trade (NACE 47)
KBO
raises risk · Last filed accounts filed 18 days late; 2 of the last 3 accounts late
NBB · filings
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 8% of 12757 sector peers (2025).
NBB · sector comparison
Position among 12757 sector peers
Solvency
better than 8%
← weakest strongest →
raises risk · 2025 accounts filed 18 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 18-08-2026, 18 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
18 days late
2024
31 days late
2023
31 days late
2022
31 days late
2021
61 days late
2020
30 days late
2019
92 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 42 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 31 August (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Risk: Negative equitydebts exceed assets in financial year 2025 -€147,015 View
  • Caution: Less equity than 95% of companies in retail tradesector median €236,771 · 12,767 companies -€147,015 View

Comparable companies

These companies have the same main activity as PHARMACIE E. DOZOT: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €467,000 and €607,000, founded between 1984 and 1993.

CompanyTotal assetsGross margin
PHARMACIE E. DOZOT Andenne€491,246€293,770
APOTHEEK DE RAM Grobbendonk€547,206€296,260
APOTHEEK DE VYLDER Alken€523,721€283,154
PHARMACIE HUART Durbuy€509,185€257,412
PHARMACO Sint-Niklaas€604,705€291,688
APOTHEEK MATTHYSSEN Brasschaat€466,800€282,271
LAMBRECHTS APOTEEK Lille€607,009€280,794
Full comparison

Documents

Annual accounts at the NBB

All 34 annual accounts

Articles and registers

Key facts about PHARMACIE E. DOZOT

What is the company number of PHARMACIE E. DOZOT?
The company number of PHARMACIE E. DOZOT is 0444.430.838. The VAT number is the same number with BE in front: BE 0444.430.838.
Where is PHARMACIE E. DOZOT based?
The registered office is at Rue de Liège 3, 5300 Andenne.Company details
What does PHARMACIE E. DOZOT do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of PHARMACIE E. DOZOT?
The legal form of PHARMACIE E. DOZOT is Private limited company (BV).
When was PHARMACIE E. DOZOT founded?
PHARMACIE E. DOZOT was founded on 21-06-1991.
Is PHARMACIE E. DOZOT still active?
Yes, PHARMACIE E. DOZOT is an active enterprise in the KBO register.
How many employees does PHARMACIE E. DOZOT have?
PHARMACIE E. DOZOT had an average of 3.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of PHARMACIE E. DOZOT?
The turnover in financial year 2025 is ≈ €1.1m. This figure is estimated from the gross margin of €293,770 and 47 comparable companies (NACE 477). It probably lies between €830,000 and €1.8m.
Is PHARMACIE E. DOZOT profitable?
In financial year 2025, PHARMACIE E. DOZOT made a profit of €38,700.
Where can I find the annual accounts of PHARMACIE E. DOZOT?
PHARMACIE E. DOZOT filed 34 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of PHARMACIE E. DOZOT due?
PHARMACIE E. DOZOT must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.